White Kidney Bean Extract trials recruiting now

1 registration that name white Kidney Bean Extract as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 1 registration

Status

All 1 registrations

RecruitingNCT07705191

Effect of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control

  • No phase
  • TCI Co., Ltd.
  • About 30 people
  • Started Jul 9, 2026

In plain words A study of white Kidney Bean Extract in people 18 and older, run by TCI Co., Ltd.. It plans to enroll about 30 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older; healthy volunteers accepted. Conditions: Blood Sugar (Glucose) Control; Postprandial Glucose.

  • Adults aged 18 years or older;
  • Fasting blood glucose level < 100 mg/dL;
  • Individuals without type 1 or type 2 diabetes.

The exclusion criteria are on the listing.

What it tests, as registered

Peanut skin extract; White kidney bean extract; Water

Registered summary

The objective of this study is to investigate the effects of pre-meal supplementation with SugarLock® peanut skin extract and white kidney bean extract on reducing or delaying postprandial blood glucose elevation and glycemic fluctuations, and to evaluate their potential as nutritional supplements for postprandial glycemic management.

Where, as registered

No US site; Taiwan (1).

ClinicalTrials.gov lists 2 open registrations for this search, including ones where white Kidney Bean Extract is not a study arm or that are past the 1 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.